Status:
COMPLETED
A Feasibility Study of Multimodal Exercise/Nutrition/Anti-inflammatory Treatment for Cachexia - the Pre-MENAC Study
Lead Sponsor:
Norwegian University of Science and Technology
Collaborating Sponsors:
University of Edinburgh
Oslo University Hospital
Conditions:
Cancer
Cachexia
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
A multicentre, open, randomized phase II study comparing a multimodal intervention (oral nutritional supplements, celecoxib and physical exercise) for cachexia versus standard cancer care.
Eligibility Criteria
Inclusion
- Main eligibility criteria:
- Advanced non-small-cell lung cancer (stage III-IV) or pancreatic cancer not eligible for curative therapy
- Due to commence chemo- or chemo radiotherapy
- Karnofsky Performance Score ≥ 70
- A life expectancy of ≥4 months and considered able to complete 2 months of the study
Exclusion
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2014
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT01419145
Start Date
October 1 2011
End Date
November 1 2014
Last Update
June 16 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Oslo University Hospital Ullevål
Oslo, Norway
2
St Olavs Hospital
Trondheim, Norway
3
University of Edinburgh
Edinburgh, United Kingdom